Please ensure Javascript is enabled for purposes of website accessibility

Clorox Gets Bleached Out

By Stephen D. Simpson, Simpson, – Updated Nov 16, 2016 at 2:11PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

High commodity prices have stolen away growth and cash flow.

It's no surprise to hear that high commodity prices are starting to bite into corporate profits. After all, when you depend upon chemicals, resins, and the like, but you can't really raise the prices of your finished products, you've got a problem. Accordingly, Clorox (NYSE:CLX) posted disappointing results for the third quarter, which ended in March.

Total sales were up about 3% for the period on the basis of a similar increase in sales volume. While sales in Latin America were once again quite strong, and sales of home care, litter, and Glad products were good, there was weakness in more-seasonal product categories like charcoal, auto care, and salad dressings.

Gross margin was a bit ugly. It fell by 260 basis points as the aforementioned commodity costs took their bite. Good cost control, particularly on the selling and administrative expense line, recouped much of this, and operating margin for the third quarter actually ticked up a little over last year. On a net basis, though, profits were down more than 6%.

Not surprisingly, cash flow was also affected. Operating cash flow for the quarter dropped significantly ($58 million vs. $203 million), and as a result, year-to-date operating cash flow is lagging the year-ago level.

Clorox isn't exactly a scintillating company or stock, but overall, it's done pretty well over the past 10 years. What's more, it now trades at a discount to its industry and competitors like Colgate-Palmolive (NYSE:CL) and Procter & Gamble (NYSE:PG), though it should be noted that it's a much smaller company.

The company faces some challenges, like recovering from these high commodity costs and dealing with increasingly powerful retailers like Wal-Mart (NYSE:WMT), but the company has at least a few things going for it. The company's brands are well-known (who doesn't have a Clorox product in their house?), the business generally generates good cash flow, and management has a good track record of sharing cash with shareholders.

Given that the company still has a double-digit return on assets, decent margins, and a reasonable valuation, it's not a terrible candidate for investors looking to add a somewhat defensive name. While this quarter's underperformance may lead some to question its status as a "defensive stock," I'd argue that this quarter was more of a hiccup than a train wreck.

For more on the consumer goods sector:

Fool contributor Stephen Simpson has no financial interest in any stocks mentioned (that means he's neither long nor short the shares).

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Walmart Stock Quote
Walmart
WMT
$131.31 (0.96%) $1.25
The Procter & Gamble Company Stock Quote
The Procter & Gamble Company
PG
$135.71 (0.10%) $0.13
The Clorox Company Stock Quote
The Clorox Company
CLX
$140.03 (-1.09%) $-1.55
Colgate-Palmolive Company Stock Quote
Colgate-Palmolive Company
CL
$75.00 (-0.70%) $0.53

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.